Joel F. Martin
Fundador en Dauntless Pharmaceuticals, Inc. .
Perfil
Joel F.
Martin is the founder of Sofinnova Investments, Inc. (1974) and Dauntless Pharmaceuticals, Inc. (2015).
He held the title of President & Chief Executive Officer at Sofinnova Investments, Inc. and President, Chief Executive Officer & Director at Dauntless Pharmaceuticals, Inc. (current).
Dr. Martin is also the founder of Argonaut Technologies, Inc., Quantum Dot Corp., Intrepida Bio, Inc., and other companies.
Currently, he is the President, Chief Executive Officer & Director at Dauntless 1, Inc. and Dauntless 2, Inc. He previously held the position of President, Chief Executive Officer & Director at Cebix, Inc. and Altair Therapeutics, Inc. He was also a Director at Hypnion, Inc. and a Principal at Institutional Venture Partners.
Dr. Martin's education includes a doctorate from the University of California San Diego and an undergraduate degree and MBA from the University of Michigan.
Cargos activos de Joel F. Martin
| Empresas | Cargo | Inicio |
|---|---|---|
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Fundador | 01/05/2015 |
Dauntless 2, Inc.
 Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA. | Director Ejecutivo | - |
Dauntless 1, Inc.
 Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA. | Director Ejecutivo | - |
Intrepida Bio, Inc.
 Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Fundador | - |
Antiguos cargos conocidos de Joel F. Martin.
| Empresas | Cargo | Fin |
|---|---|---|
Altair Therapeutics, Inc.
 Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Director Ejecutivo | 09/03/2011 |
Forward Ventures Services LLC
 Forward Ventures Services LLC Investment ManagersFinance Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California. | Miembro del Comité de Inversión | 31/12/2008 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Director Ejecutivo | - |
Quantum Dot Corp.
 Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Director Ejecutivo | - |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Director Ejecutivo | - |
Formación de Joel F. Martin.
| University of California San Diego | Doctorate Degree |
| University of Michigan | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Argonaut Technologies, Inc.
 Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Commercial Services |
Hypnion, Inc.
 Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Hypnion, Inc. discovered and developed neuroscience drugs. It focused on the development of novel therapeutics for the treatment of central nervous system disorders to serve the underserved markets of sleep and wake-alertness disorders and circadian rhythm abnormalities. The company was founded in 2000 and was headquartered in Lexington, MA. | Commercial Services |
Quantum Dot Corp.
Quantum Dot Corp. SemiconductorsElectronic Technology Quantum Dot Corp. develops and markets novel solutions for biomolecular detection. Its products and services employ quantum dot particles, tiny semiconductor crystals that emit light brightly in a range of sharp colors. The company was founded by Bala Manian in 1998 and is located in Hayward, CA. | Electronic Technology |
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA. | Health Technology |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Finance |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures Services LLC (Forward Ventures ) is a venture capital firm founded in 1990 by Standish M. Fleming and Ivor Royston. The firm is headquartered in San Diego, California. | Finance |
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects. Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly. Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry. | Distribution Services |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA. | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Retail Trade |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA. | Health Technology |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Joel F. Martin
